|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
LU86084A1
(fr)
|
1985-09-20 |
1987-04-02 |
Faco Sa |
Apparei de massage electrique
|
|
US5102417A
(en)
|
1985-11-07 |
1992-04-07 |
Expandable Grafts Partnership |
Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
|
|
US4800882A
(en)
|
1987-03-13 |
1989-01-31 |
Cook Incorporated |
Endovascular stent and delivery system
|
|
US4886062A
(en)
|
1987-10-19 |
1989-12-12 |
Medtronic, Inc. |
Intravascular radially expandable stent and method of implant
|
|
WO1990013332A1
(en)
|
1989-05-11 |
1990-11-15 |
Cedars-Sinai Medical Center |
Stent with sustained drug delivery
|
|
DE69110787T2
(de)
|
1990-02-28 |
1996-04-04 |
Medtronic, Inc., Minneapolis, Minn. |
Intraluminale prothese mit wirkstoffeluierung.
|
|
US5419760A
(en)
|
1993-01-08 |
1995-05-30 |
Pdt Systems, Inc. |
Medicament dispensing stent for prevention of restenosis of a blood vessel
|
|
US5429634A
(en)
|
1993-09-09 |
1995-07-04 |
Pdt Systems |
Biogenic implant for drug delivery and method
|
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
|
US5833651A
(en)
|
1996-11-08 |
1998-11-10 |
Medtronic, Inc. |
Therapeutic intraluminal stents
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
EP1193256A1
(en)
*
|
2000-09-27 |
2002-04-03 |
Applied Research Systems ARS Holding N.V. |
Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
|
|
JP2004526733A
(ja)
|
2001-03-20 |
2004-09-02 |
メルク エンド カムパニー インコーポレーテッド |
強力な細胞接着阻害剤としての置換ｎ−アリールスルホニル−プロリン誘導体
|
|
AR036366A1
(es)
|
2001-08-29 |
2004-09-01 |
Schering Corp |
Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
|
|
CN100567266C
(zh)
|
2001-11-14 |
2009-12-09 |
先灵公司 |
类大麻苷受体配体
|
|
CA2475766C
(en)
|
2002-03-13 |
2012-06-05 |
Janssen Pharmaceutica N.V. |
Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
|
|
EA007099B1
(ru)
|
2002-03-13 |
2006-06-30 |
Янссен Фармацевтика Н. В. |
Сульфонилпроизводные в качестве ингибиторов гистон-деацетилазы
|
|
MXPA04008797A
(es)
|
2002-03-13 |
2004-11-26 |
Janssen Pharmaceutica Nv |
Inhibidores de histona desacetilasa.
|
|
HRP20040805A2
(en)
|
2002-03-13 |
2005-04-30 |
Janssen Pharmaceutica N.V. |
Carbonylamino derivatives as novel inhibitors histone deacetylase
|
|
US6770729B2
(en)
|
2002-09-30 |
2004-08-03 |
Medtronic Minimed, Inc. |
Polymer compositions containing bioactive agents and methods for their use
|
|
US7041693B2
(en)
|
2002-10-04 |
2006-05-09 |
Bristol-Myers Squibb Company |
Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
|
|
SE0302116D0
(sv)
|
2003-07-21 |
2003-07-21 |
Astrazeneca Ab |
Novel compounds
|
|
RU2321586C2
(ru)
|
2003-08-12 |
2008-04-10 |
Ф.Хоффманн-Ля Рош Аг |
Производные тиазола в качестве антагонистов npy
|
|
JP2005119987A
(ja)
|
2003-10-15 |
2005-05-12 |
Ajinomoto Co Inc |
アシルスルホンアミド誘導体
|
|
BRPI0515500A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados piridazina para inibição de estearoil-coa-desaturase
|
|
EP2407459A1
(en)
|
2005-09-27 |
2012-01-18 |
Shionogi & Co., Ltd. |
Synthetic intermediate in the production of a sulfonamide derivative having PGD2 receptor antagonistic activity
|
|
WO2007047431A2
(en)
|
2005-10-12 |
2007-04-26 |
Kalypsys, Inc. |
Sulfonyl-substituted aryl compounds as modulators of peroxisome proliferator activated receptors
|
|
WO2007092435A2
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
11-beta hsd1 inhibitors
|
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
|
WO2009158587A1
(en)
|
2008-06-26 |
2009-12-30 |
Inspire Pharmaceuticals, Inc. |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
US20100204210A1
(en)
|
2008-12-04 |
2010-08-12 |
Scott Sorensen |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
SG172352A1
(en)
|
2008-12-23 |
2011-07-28 |
Abbott Lab |
Anti-viral compounds
|
|
JP2013047189A
(ja)
|
2009-12-25 |
2013-03-07 |
Kyorin Pharmaceutical Co Ltd |
新規パラバン酸誘導体及びそれらを有効成分とする医薬
|
|
US8981084B2
(en)
|
2010-01-13 |
2015-03-17 |
Tempero Pharmaceuticals, Inc. |
Oxadiazole HDAC inhibitors
|
|
JP2013531063A
(ja)
|
2010-07-19 |
2013-08-01 |
インスパイアー ファーマシューティカルズ，インコーポレイティド |
二官能基Ｒｈｏキナーゼ阻害化合物、組成物およびその使用
|
|
EP2597953A4
(en)
|
2010-07-27 |
2013-12-25 |
Inspire Pharmaceuticals Inc |
METHOD FOR THE TREATMENT OF EYE DISEASES USING KINASE-INHIBITOR COMPOUNDS IN PRODRUG FORMS
|
|
WO2013157021A1
(en)
|
2012-04-20 |
2013-10-24 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
|
CN105263910A
(zh)
|
2013-02-18 |
2016-01-20 |
斯克利普斯研究所 |
具有治疗潜力的血管加压素受体调节剂
|
|
CA2927924A1
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of proliferative diseases
|
|
CR20160296A
(es)
|
2013-11-27 |
2016-09-20 |
Genentech Inc |
Benzamidas sustituidas y métodos para usarlas
|
|
EP3076968B1
(en)
|
2013-12-02 |
2019-04-17 |
ChemoCentryx, Inc. |
Ccr6 compounds
|
|
EP3105218B1
(en)
|
2014-02-13 |
2019-09-25 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
US9974784B2
(en)
|
2015-01-21 |
2018-05-22 |
The Texas A&M University System |
Inhibitors of activin-like receptor kinases
|
|
US10442788B2
(en)
*
|
2015-04-01 |
2019-10-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
|
KR20180026459A
(ko)
|
2015-06-18 |
2018-03-12 |
세파론, 인코포레이티드 |
1,4-치환된 피페리딘 유도체
|
|
JP6947651B2
(ja)
|
2015-06-26 |
2021-10-13 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
４，６−ピリミジニレン誘導体およびこれらの使用
|
|
WO2017070320A1
(en)
|
2015-10-21 |
2017-04-27 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Phenyl indole allosteric inhibitors of p97 atpase
|
|
EP3854782A1
(en)
|
2016-03-30 |
2021-07-28 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
CA3026982A1
(en)
|
2016-06-08 |
2017-12-14 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds as atf4 pathway inhibitors
|
|
AU2017363307B2
(en)
|
2016-11-22 |
2021-07-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
TW202012370A
(zh)
|
2018-04-18 |
2020-04-01 |
美商德洛斯股份有限公司 |
具氰基丙烯基醯胺部分之k-ras調節劑
|
|
WO2019204505A2
(en)
|
2018-04-18 |
2019-10-24 |
Theras, Inc. |
K-ras modulators with a vinyl sulfonamide moiety
|
|
EP3813819A4
(en)
|
2018-06-29 |
2022-08-17 |
Kinnate Biopharma Inc. |
CYCLIN-DEPENDENT KINASE INHIBITORS
|
|
EP3820500A4
(en)
|
2018-07-13 |
2022-04-13 |
Teqla Therapeutics, Inc. |
USE OF BCL6 INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
|
|
BR112022009881A2
(pt)
|
2019-11-22 |
2022-10-11 |
Univ California |
Inibidores de caspase 6 e usos dos mesmos
|
|
CN113135896B
(zh)
|
2020-01-18 |
2024-12-06 |
正大天晴药业集团股份有限公司 |
作为ret抑制剂的甲基吡唑类衍生物
|
|
WO2022173849A1
(en)
*
|
2021-02-10 |
2022-08-18 |
Qilu Regor Therapeutics Inc. |
(hetero)arylamino-cyclohexyl-sulfonyl derivatives as ccr6 inhibitors
|
|
AU2022328634A1
(en)
*
|
2021-08-18 |
2024-02-22 |
Chemocentryx, Inc. |
Aryl sulfonyl compounds as ccr6 inhibitors
|